1.
Int J Dermatol
; 63(2): 251-253, 2024 Feb.
Article
En
| MEDLINE
| ID: mdl-38031284
2.
Int J Dermatol
; 63(2): e47-e49, 2024 Feb.
Article
En
| MEDLINE
| ID: mdl-38093419
3.
Am J Ther
; 30(5): e461-e463, 2023.
Article
En
| MEDLINE
| ID: mdl-37713694
4.
Am J Ther
; 30(6): e544-e546, 2023.
Article
En
| MEDLINE
| ID: mdl-36881440
5.
Am J Ther
; 30(6): e547-e548, 2023.
Article
En
| MEDLINE
| ID: mdl-36856587
6.
Int J Rheum Dis
; 26(7): 1407-1409, 2023 07.
Article
En
| MEDLINE
| ID: mdl-36880735
7.
A novel missense mutation in the MVK gene is associated with disseminated superficial porokeratosis.
Int J Dermatol
; 62(4): e223-e225, 2023 04.
Article
En
| MEDLINE
| ID: mdl-36371681
8.
Am J Dermatopathol
; 44(12): 940-942, 2022 Dec 01.
Article
En
| MEDLINE
| ID: mdl-36197045
ABSTRACT: The combination of paraneoplastic pemphigus and prostate cancer is extremely unusual and has not been reported yet. Paraneoplastic pemphigus is caused by tumor-induced autoantibodies, which cause damage to the skin and mucosa. The essential treatment is active tumor control. Our patient received a robot-assisted radical prostatectomy and glucocorticoid therapy to improve his condition and relieve his skin lesions.
Paraneoplastic Syndromes , Pemphigus , Prostatic Neoplasms , Humans , Male , Autoantibodies , Paraneoplastic Syndromes/pathology , Pemphigus/complications , Prostatic Neoplasms/complications , Prostatic Neoplasms/pathology , Skin/pathology